Stock-Based Compensation - Summary of Stock Option Activity (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended	12 Months Ended
Mar. 31, 2020	Dec. 31, 2019
Number of Shares
Beginning balance (in shares)	1,297,029
Granted (in shares)	206,775
Exercised (in shares)	(13,006)
Forfeited (in shares)	(22,593)
Ending balance (in shares)	1,468,205	1,297,029
Number of shares Options, Exercisable (in shares)	543,825
Number of shares Options, Vested and expected to vest (in shares)	1,270,027
Weighted Average Exercise Price
Beginning balance (in usd per share)	$ 17.05
Granted (in usd per share)	10.22
Exercised (in usd per share)	7.38
Forfeited (in usd per share)	17.46
Ending balance (in usd per share)	16.17	$ 17.05
Weighted average exercise price, Exercisable (in usd per share)	21.17
Weighted average exercise price, Vested and expected to vest (in usd per share)	$ 16.32
Weighted average contractual term outstanding (in years)	8 years 4 months 24 days	8 years 4 months 24 days
Weighted average contractual term outstanding, Exercisable (in years)	7 years 1 month 6 days
Weighted average contractual term outstanding, Vested and expected to vest (in years)	8 years 3 months 18 days
Aggregate intrinsic value, Beginning balance	$ 1,286
Aggregate intrinsic value, Ending balance	958	$ 1,286
Aggregate intrinsic value, exercisable	771
Aggregate intrinsic value, vested and expected to vest	$ 938

The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.